Live from the NIH registry
Studies recruiting near Mobile right now
Top 25 of 164 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
University of South Alabama (USA) Physicians Group — Mobile, Alabama (4.5 mi)
· Sponsor: Takeda
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
The Center for Clinical Trials - Saraland /ID# 271604 — Saraland, Alabama (10.2 mi)
· Sponsor: AbbVie
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 990 participants sought
Research Site — Mobile, Alabama (4.5 mi)
· Sponsor: AstraZeneca
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
University of South Alabama, Mitchell Cancer Institute ( Site 6033) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Breast Cancer
Phase 3
Interventional 750 participants sought
Southern Cancer Center — Mobile, Alabama (4.5 mi)
· Sponsor: Greenwich LifeSciences, Inc.
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Overactive Bladder, Urge Incontinence
N/A
Interventional 200 participants sought
USA Health — Mobile, Alabama (4.5 mi)
· Sponsor: Valencia Technologies Corporation
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 3
Interventional 800 participants sought
Research Site — Daphne, Alabama (13.7 mi)
· Sponsor: AstraZeneca
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Associates of Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Pacific Edge Limited
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
University of South Alabama Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: NRG Oncology
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Mobile, Alabama (4.5 mi)
· Sponsor: DalCor Pharmaceuticals
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: Children's Oncology Group
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 700 participants sought
Site 164 — Mobile, Alabama (4.5 mi)
· Sponsor: Merus B.V.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
Southern Cancer Center, PC — Daphne, Alabama (13.7 mi)
· Sponsor: Stemline Therapeutics, Inc.
MYLUNG Consortium Part 3: Observational Study
Carcinoma, Non-Small-Cell Lung
N/A
Observational 7,500 participants sought
Southern Cancer Center, PC — Daphne, Alabama (13.7 mi)
· Sponsor: US Oncology Research
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: SWOG Cancer Research Network
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Mobile Heart Specialists — Mobile, Alabama (4.5 mi)
· Sponsor: Novartis Pharmaceuticals
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
Phase 3
Interventional 4,390 participants sought
USA Health University Hospitals ( Site 0020) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
The Center for Clinical Trials — Saraland, Alabama (10.2 mi)
· Sponsor: Ardelyx
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Phase 3
Interventional 492 participants sought
Infirmary Cancer Care — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
The Center for Clinical Trials - Saraland /ID# 231546 — Saraland, Alabama (10.2 mi)
· Sponsor: AbbVie
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Mobile, Alabama (4.5 mi)
· Sponsor: TG Therapeutics, Inc.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Mobile, Alabama (4.5 mi)
· Sponsor: Massive Bio, Inc.
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Persistent Atrial Fibrillation
N/A
Interventional 376 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: Boston Scientific Corporation
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
University of South Alabama Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: National Cancer Institute (NCI)